PKCα deficiency in mice is associated with pulmonary vascular hyperresponsiveness to thromboxane A2 via increased TXA2 receptor expression

被引：0
|
作者：
Tabeling, Christoph
Noe, Elena
Naujoks, Jan
Doehn, Jan-Moritz
Hippenstiel, Stefan
Opitz, Bastian
Suttorp, Norbert
Klopfleisch, Robert
Witzenrath, Martin
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Pulmonary hypertension;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P308
引用
收藏
页数：4
相关论文
共 50 条
  • [21] THROMBOXANE A2 RECEPTORS IN EQUINE MONOCYTES - IDENTIFICATION OF A NEW SUBCLASS OF TXA2 RECEPTORS
    SIMMONS, TR
    COOK, JA
    MOORE, JN
    HALUSHKA, PV
    JOURNAL OF LEUKOCYTE BIOLOGY, 1993, 53 (02) : 173 - 178
  • [22] Directed vascular expression of the thromboxane A2 receptor.
    Rocca, B
    Loeb, AL
    Eng, V
    Vezza, R
    Habib, A
    Funk, CD
    FitzGerald, GA
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (03) : 230A - 230A
  • [23] PHARMACODYNAMICS OF AN INTRAVENOUSLY ADMINISTERED THROMBOXANE (TXA2) RECEPTOR (R) ANTAGONIST
    FRIEDHOFF, LT
    RANIELE, D
    HALSTENSON, CE
    SMITH, SA
    HEDBERG, A
    LIU, E
    SHEPARD, JH
    KEANE, WF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (02) : 123 - 123
  • [24] FAILURE OF DOG PLATELETS TO RESPOND TO THROMBOXANE A2 (TXA2) IS DUE TO A DYSFUNCTIONAL RECEPTOR-LINKED G PROTEIN
    JOHNSON, GJ
    DUNLOP, PC
    LEIS, LA
    ARTERIOSCLEROSIS, 1988, 8 (05): : A716 - A716
  • [25] Stimulation with thromboxane A2 (TXA2) receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endothelial cells
    Ishizuka, T
    Kawakami, M
    Hidaka, T
    Matsuki, Y
    Takamizawa, M
    Suzuki, K
    Kurita, A
    Nakamura, H
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 112 (03): : 464 - 470
  • [26] Changes of the plasma levels of thromboxane A2 (TXA2) in patients with different stage of renal failure
    Karamouzis, I.
    Sioulis, A.
    Karamouzis, M.
    Triantos, A.
    Kalaras, K.
    Dimitriadou, A.
    Grekas, D.
    FEBS JOURNAL, 2006, 273 : 159 - 159
  • [27] PLATELET ENDOPEROXIDE/THROMBOXANE A2 (PGH2/TXA2) RECEPTORS IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS
    FAUL, C
    RENN, W
    JASCHONEK, K
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1991, 43 (04): : 273 - 276
  • [28] EFFECTS OF PROSTAGLANDINS (PGS) AND THROMBOXANE A2 (TXA2) ON CORONARY CIRCULATION OF ADULT AND PUPPY DOGS
    WANG, HH
    KULKARNI, PS
    EAKINS, KE
    FEDERATION PROCEEDINGS, 1978, 37 (03) : 731 - 731
  • [29] Role of PKCζ in the pulmonary vasoconstrictor effects of thromboxane A2
    Cogolludo, A
    Moreno, L
    Bosca, L
    Tamargo, J
    Perez-Vizcaino, F
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140
  • [30] AN AFFINITY COLUMN FOR PURIFICATION OF THE HUMAN-PLATELET THROMBOXANE A2 PROSTAGLANDIN H2 (TXA2/PGH2) RECEPTOR
    VENTON, DL
    ARORA, SK
    KIM, SO
    LIM, CT
    LEBRETON, GC
    FEDERATION PROCEEDINGS, 1987, 46 (06) : 1943 - 1943
12345